TCL Archive Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer By Cancer History Project April 30, 2004
TCL Archive SPOREs hammer out research agenda, seek $50,000 from NCI for further tissue analysis. By Cancer History Project April 30, 2004
TCL Archive Dramatic responses to Iressa prompted further bench research. Results have limited clinical relevance, for now, but findings may explain failure of INTACT studies. By Cancer History Project April 30, 2004
TCL Archive Regular Exercise May Prevent Cancer, Improve Survival By Cancer History Project April 30, 2004
TCL Archive Cancer Deaths In Black Men Could Drop By Cutting Tobacco By Cancer History Project April 30, 2004
TCL Archive NCI blocked groups from phase III Iressa studies. By Cancer History Project April 30, 2004
TCL Archive Also in this 8-page issue: Amgen names PhRMA executive Rodger Currie vice president for government affairs. By Cancer History Project April 30, 2004
TCL Archive Surgery Lowers Risk By 90% In Women With Gene Mutations By Cancer History Project April 30, 2004
Article Fran Visco tells the story of NBCC: “Women have declared war on breast cancer” By Cancer History Project
